A 6-Month, Placebo-Controlled Study Comparing Lung Function and Health Status Changes in COPD Patients Treated With Tiotropium or Salmeterol

This publication has 22 references indexed in Scilit:

• A randomised controlled comparison of tiotropium and ipratropium in the treatment of chronic obstructive pulmonary disease
  Thorax, 2000
• An empirical comparison of the St George's Respiratory Questionnaire (SGRQ) and the Chronic Respiratory Disease Questionnaire (CRQ) in a clinical trial setting
  Thorax, 1999
• Tiotropium (SPIRIVA™): Mechanistical considerations and clinical profile in obstructive lung disease
  Life Sciences, 1999
• A comparison of the bronchodilating effects of salmeterol, salbutamol and Ipratropium bromide in patients with chronic obstructive pulmonary disease
  Pulmonary Pharmacology, 1995
• Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force
  European Respiratory Journal, 1995
• Efficacy of inhaled salmeterol in the management of smokers with chronic obstructive pulmonary disease: a single centre randomised, double blind, placebo controlled, crossover study.
  Thorax, 1995
• Tiotropium bromide (Ba 679 BR), a novel long-acting muscarinic antagonist for the treatment of obstructive airways disease
  Life Sciences, 1995
• Bronchodilator Responses to Anticholinergic and Beta-Adrenergic Agents in Acute and Stable COPD
  Chest, 1991
• A measure of quality of life for clinical trials in chronic lung disease.
  Thorax, 1987
• Role of the Parasympathetic System in Airway Obstruction Due to Emphysema
  New England Journal of Medicine, 1984